{
    "eid": "2-s2.0-85055561549",
    "title": "The benefits of angiotensin-converting enzyme inhibitors/angiotensin II receptor blockers combined with calcium channel blockers on metabolic, renal, and cardiovascular outcomes in hypertensive patients: a meta-analysis",
    "cover-date": "2018-12-01",
    "subject-areas": [
        {
            "@_fa": "true",
            "$": "Nephrology",
            "@code": "2727",
            "@abbrev": "MEDI"
        },
        {
            "@_fa": "true",
            "$": "Urology",
            "@code": "2748",
            "@abbrev": "MEDI"
        }
    ],
    "keywords": [
        "ACEIs",
        "ARBs",
        "CCBs",
        "Clinical outcomes",
        "Hypertension",
        "Meta-analysis"
    ],
    "authors": [
        "Punnaka Pongpanich",
        "Pasvich Pitakpaiboonkul",
        "Kullaya Takkavatakarn",
        "Kearkiat Praditpornsilpa",
        "Somchai Eiam-Ong",
        "Paweena Susantitaphong"
    ],
    "citedby-count": 6,
    "ref-count": 106,
    "ref-list": [
        "ACE inhibitors, beta-blockers, calcium blockers, and diuretics for the control of systolic hypertension",
        "Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required vs. atenolol adding bendroflumethiazide as required in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOTBPLA) a multicentre randomised controlled trial",
        "Usual versus tight control of systolic blood pressure in non-diabetic patients with hypertension (Cardio-Sis): an open-label randomised trial",
        "Rationale for triple fixed-dose combination therapy with an angiotensin II receptor blocker, a calcium channel blocker, and a thiazide diuretic",
        "The Comparative efficacy and safety of the angiotensin receptor blockers in the management of hypertension and other cardiovascular diseases",
        "2013 ESH/ESC Guidelines for the management of arterial hypertension: the Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC)",
        "Clinical practice guidelines for the management of hypertension in the community: a statement by the American Society of Hypertension and the International Society of Hypertension",
        "2014 evidence-based guideline for the management of high blood pressure in adults\u2014report from the panel members appointed to the Eighth Joint National Committee (JNC 8)",
        "Calcium channel blocker compared with angiotensin receptor blocker for patients with hypertension: a meta-analysis of randomized controlled trials",
        "Blood pressure and metabolic effect of a combination of lercanidipine with different antihypertensive drugs in clinical practice",
        "Renoprotective effect of the combination of renin-angiotensin system inhibitor and calcium channel blocker in patients with hypertension and chronic kidney disease",
        "Benazepril plus amlodipine or hydrochlorothiazide for hypertension in high-risk patients",
        "Angiotensin system blockade combined with calcium channel blockers is superior to other combinations in cardiovascular protection with similar blood pressure reduction: a meta-analysis in 20,451 hypertensive patients",
        "Renoprotective effects of renin-angiotensin system inhibitor combined with calcium channel blocker or diuretic in hypertensive patients: a PRISMA-compliant meta-analysis",
        "Combination therapy with an ACE inhibitor and an angiotensin receptor blocker for diabetic nephropathy: a meta-analysis",
        "Renal outcomes with telmisartan, ramipril, or both, in people at high vascular risk (the ONTARGET study): a multicentre, randomised, double-blind, controlled trial",
        "Meta-analysis of combined therapy with angiotensin receptor antagonists versus ACE inhibitors alone in patients with heart failure",
        "Dual blockade of the renin-angiotensin system with angiotensin converting enzyme (ACE) inhibitors and angiotensin receptor blockers (ARBs)",
        "PRAC recommends against combined use of medicines affecting the renin-angiotensin (RAS) system",
        "JNC8 guidelines for the management of hypertension in adults",
        "Assessing the quality of reports of randomized clinical trials: is blinding necessary",
        "Assessing heterogeneity in meta-analysis: Q statistic or I2 index",
        "Bias in meta-analysis detected by a simple, graphical test",
        "A diuretic is more effective than a beta- blocker in hypertensive patients not controlled on amlodipine and Lisinopril",
        "Metabolic neutrality of combined verapamil-trandolapril treatment in contrast to beta-blocker-low-dose chlortalidone treatment in hypertensive type 2 diabetes",
        "Comparison of different fixed antihypertensive combination drugs: a double-blind, placebo-controlled parallel group study",
        "Evaluation of the effects of fixed combinations of sustained-release verapamil/trandolapril versus captopril/hydrochlorothiazide on metabolic and electrolyte parameters in patients with essential hypertension",
        "Effect of two antihypertensive combinations on metabolic control in type-2 diabetic hypertensive patients with albuminuria: a randomised, double-blind study",
        "Comparison of the effects of an ACE inhibitor and alpha beta blocker on the progression of renal failure with left ventricular hypertrophy: preliminary report",
        "Pilot study to evaluate a water displacement technique to compare effects of diuretics and ACE inhibitors to alleviate lower extremity edema due to dihydropyridine calcium antagonists",
        "Comparison of benazepril-amlodipine and captopril-thiazide combinations in the management of mild-to-moderate hypertension",
        "Metabolic effects of combined antihypertensive treatment in patients with essential hypertension",
        "Antihypertensive therapy with verapamil SR plus trandolapril versus atenolol plus chlorthalidone on glycemic control",
        "Effect of delapril-manidipine combination vs irbesartan-hydrochlorothiazide combination on fibrinolytic function in hypertensive patients with type II diabetes mellitus",
        "Comparison of the antihypertensive effects of the fixed dose combination enalapril 10 mg/nitrendipine 20 mg vs losartan 50 mg/hydrochlorothiazide 12.5 mg, assessed by 24-h ambulatory blood pressure monitoring, in essential hypertensive patients",
        "Comparison of antihypertensive effects of an angiotensin-converting enzyme inhibitor, a calcium antagonist and a diuretic in patients with hypertension not controlled by angiotensin receptor blocker monotherapy",
        "Efficacy and safety of lercanidipine versus hydrochlorothiazide as add-on to enalapril in diabetic populations with uncontrolled hypertension",
        "Differences in glucose tolerance between fixed-dose antihypertensive drug combinations in people with metabolic syndrome",
        "Additional antihypertensive effect of drugs in hypertensive subjects uncontrolled on diltiazem monotherapy: a randomized controlled trial using office and home blood pressure monitoring",
        "Addition of manidipine improves the antiproteinuric effect of candesartan in hypertensive patients with type II diabetes and microalbuminuria",
        "Efficacy and safety of olmesartan medoxomil and hydrochlorothiazide compared with benazepril and amlodipine besylate",
        "Tolerability and blood pressure-lowering efficacy of the combination of amlodipine plus valsartan compared with lisinopril plus hydrochlorothiazide in adult patients with stage 2 hypertension",
        "Effectiveness of add-on low-dose diuretics in combination therapy for hypertension: losartan/hydrochlorothiazide vs. candesartan/amlodipine",
        "Effects of different ACE inhibitor combinations on albuminuria: results of the GUARD study",
        "Effect of delapril/manidipine vs olmesartan/hydrochlorothiazide combination on insulin sensitivity and fibrinogen in obese hypertensive patients",
        "Effects of manidipine/delapril versus olmesartan/hydrochlorothiazide combination therapy in elderly hypertensive patients with type 2 diabetes mellitus",
        "Comparative evaluation of effect of valsartan/amlodipine and atenolol/amlodipine combinations on atrial fibrillation recurrence in hypertensive patients with type 2 diabetes mellitus",
        "Efficacy of manidipine/delapril versus losartan/hydrochlorothiazide fixed combinations in patients with hypertension and diabetes",
        "Amlodipine/valsartan/hydrochlorothiazide triple combination therapy in moderate/severe hypertension: secondary analyses evaluating efficacy and safety",
        "Efficacy and safety of two treatment combinations of hypertension in very elderly patients",
        "Angiotensin-II receptor antagonist combined with calcium channel blocker or diuretic for essential hypertension",
        "Add-on benefits of amlodipine and thiazide in nondiabetic chronic kidney disease stage 1/2 patients treated with valsartan",
        "Fixed-dose manidipine/delapril versus losartan/hydrochlorothiazide in hypertensive patients with type 2 diabetes and microalbuminuria",
        "Differential effects between a calcium channel blocker and a diuretic when used in combination with angiotensin II receptor blocker on central aortic pressure in hypertensive patients",
        "Magnetic resonance imaging left ventricular mass reduction with fixed-dose angiotensin-converting enzyme inhibitor-based regimens in patients with high-risk hypertension",
        "Amlodipine-valsartan combination decreases central systolic blood pressure more effectively than the amlodipine-atenolol combination: the EXPLOR study",
        "Combination therapy of calcium channel blocker and angiotensin II receptor blocker reduces augmentation index in hypertensive patients",
        "Triple therapy with olmesartan medoxomil, amlodipine besylate, and hydrochlorothiazide in adult patients with hypertension: the TRINITY multicenter, randomized, double-blind, 12-week, parallel-group study",
        "Efficacy and tolerability of a fixed-dose combination of metoprolol extended release/amlodipine in patients with mild-to-moderate hypertension: a randomized, parallel-group, multicentre comparison with losartan plus amlodipine",
        "Combination of angiotensin II receptor antagonist with calcium channel blocker or diuretic as antihypertensive therapy for patients with chronic kidney disease",
        "Comparison of combination therapies, including the angiotensin receptor blocker olmesartan and either a calcium channel blocker or a thiazide diuretic, in elderly patients with hypertension",
        "Olmesartan/amlodipine vs olmesartan/hydrochlorothiazide in hypertensive patients with metabolic syndrome: the OLAS study",
        "Prevention of cardiovascular events with calcium channel blocker-based combination therapies in patients with hypertension: a randomized controlled trial",
        "Comparison of the efficacy and safety profiles of two fixed-dose combinations of antihypertensive agents, amlodipine/benazepril versus valsartan/hydrochlorothiazide, in patients with type 2 diabetes mellitus and hypertension: a 16-week, multicenter, randomized, double-blind, noninferiority study",
        "Combination of amlodipine plus angiotensin receptor blocker or diuretics in high-risk hypertensive patients: a 96-week efficacy and safety study",
        "Effect of felodipine with irbesartan or metoprolol on sexual function and oxidative stress in women with essential hypertension",
        "Efficacy and safety of triple antihypertensive therapy with the olmesartan/amlodipine/hydrochlorothiazide combination",
        "Effects of carvedilol as third-line add-on therapy on blood pressure and glucose metabolism in type 2 diabetic patients with chronic renal disease stage 3 and above",
        "Distinct effects of fixed combinations of valsartan with either amlodipine or hydrochlorothiazide on lipoprotein subfraction profile in patients with hypertension",
        "Kidney-protective effects of azelnidipine versus a diuretic in combination with olmesartan in hypertensive patients with diabetes and albuminuria: a randomized study",
        "Newer versus Older Antihypertensive Agents in African Hypertensive Patients Trial (NOAAH) Investigators. Efficacy of newer versus older antihypertensive drugs in black patients living in sub-Saharan Africa",
        "Changes in biomarkers and 24 hours blood pressure in hypertensive African Americans with the metabolic syndrome: comparison of amlodipine/olmesartan versus hydrochlorothiazide/losartan",
        "Efficacy and effects on lipid metabolism of combination treatment with losartan + hydrochlorothiazide versus losartan + amlodipine: a 48-week prospective, multicenter, randomized, open-label trial",
        "Effect of Anti-hypertensive therapy on Regression of Cardiac Hypertrophy (E-SEARCH) trial investigators. Comparison of the effect of combination therapy with an angiotensin II receptor blocker and either a low-dose diuretic or calcium channel blocker on cardiac hypertrophy in patients with hypertension",
        "CAMUI investigators. Combination of antihypertensive therapy in the elderly, multicenter investigation (CAMUI) trial: results after 1 year",
        "The effect of combined antihypertensive treatment (felodipine with either irbesartan or metoprolol) on erectile function: a randomized controlled trial",
        "COLM Investigators. Combinations of olmesartan and a calcium channel blocker or a diuretic in elderly hypertensive patients: a randomized, controlled trial",
        "Angiotensin receptor blocker (ARB)-diuretic versus ARB-calcium channel blocker combination therapy for hypertension uncontrolled by ARB monotherapy",
        "Efficacy and tolerability of amlodipine camsylate/losartan 5/100-mg versus losartan/hydrochlorothiazide 100/12.5-mg fixed-dose combination in hypertensive patients nonresponsive to losartan 100-mg monotherapy",
        "Effects of combination therapy with olmesartan and azelnidipine on serum osteoprotegerin in patients with hypertension",
        "Add-on effect of hydrochlorothiazide 12.5 mg in Japanese subjects with essential hypertension uncontrolled with losartan 50 mg and amlodipine 5 mg",
        "Choice of antihypertensive combination therapy based on daily salt intake",
        "K/DOQI clinical practice guidelines for cardiovascular disease in dialysis patients",
        "Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy",
        "Preserving renal function in adults with hypertension and diabetes: a consensus approach. National Kidney Foundation Hypertension and Diabetes Executive Committees Working Group",
        "Renoprotective effect of the angiotensin-receptor antagonist Irbesartan in patients with nephropathy due to type 2 diabetes",
        "To study the efficacy of Losartan on urinary uric acid excretion in Thiazide induced hyperuricemic and hypertensive patients",
        "The effect of trandolapril and its fixed-dose combination with verapamil on proteinuria in normotensive adults with type 2 diabetes",
        "Efficacy and safety of combined vs. single renin-angiotensin-aldosterone system blockade in chronic kidney disease: a meta-analysis",
        "Amlodipine and valsartan: calcium channel blockers/angiotensin II receptor blockers combination for hypertension",
        "Amlodipine, enalapril, and dependent leg edema in essential hypertension",
        "Comparison of efficacy and side effects of combination therapy of angiotensin-converting enzyme inhibitor (benazepril) with calcium antagonist (either nifedipine or amlodipine) versus high-dose calcium antagonist monotherapy for systemic hypertension",
        "Metabolic syndrome and chronic kidney disease: Current status and future directions",
        "Angiotensin-converting enzyme inhibitors and insulin sensitivity: metabolic effects in hypertension, diabetes, and heart failure",
        "Modulation of metabolic control by angiotensin converting enzyme (ACE) inhibition",
        "The renin angiotensin aldosterone system and insulin resistance in humans",
        "Calcium channel blocker azelnidipine reduces glucose intolerance in diabetic mice via different mechanism than angiotensin receptor blocker olmesartan",
        "Effects of calcium channel blockers on glucose tolerance, inflammatory state, and circulating progenitor cells in non-diabetic patients with essential hypertension: a comparative study between azelnidipine and amlodipine on glucose tolerance and endothelial function\u2014a crossover trial (AGENT)",
        "Metabolic adverse effects of thiazide diuretics: the importance of normokalaemia",
        "Drug-induced glucose alterations part 2: drug-induced hyperglycemia",
        "Drug-induced metabolic syndrome",
        "The HbA1c and all-cause mortality relationship in patients with type 2 diabetes is J-shaped: a meta-analysis of observational studies",
        "The impact of diabetes mellitus and corresponding HbA1c levels on the future risks of cardiovascular disease and mortality: a representative Cohort Study in Taiwan",
        "Hyperuricemia and the risk for coronary heart disease morbidity and mortality a systematic review and dose-response meta-analysis",
        "Relationship between serum uric acid levels and hypertension among Japanese individuals not treated for hyperuricemia and hypertension"
    ],
    "affiliation": {
        "affiliation-city": "Bangkok",
        "@id": "60028190",
        "affilname": "Chulalongkorn University",
        "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190",
        "affiliation-country": "Thailand"
    },
    "funding": []
}